Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

Naked Brand Stock Probably Won’t Rally

By Thomas Niel, InvestorPlace Contributor

The company could be boosted by an e-commerce catalyst. But if you buy NAKD stock, keep in mind that your losses could be substantial.

There’s No Need to Chase Robinhood Stock After its IPO

By Thomas Niel, InvestorPlace Contributor

Bottom line: too pricey, and too trendy, the best move with HOOD stock is to hold off buying.

Clover Stock Has Limited Rebound Potential, So Stay Away

By Thomas Niel, InvestorPlace Contributor

Bottom line: skip out on CLOV stock, and stick with the Reddit favorites stronger prospects.

NeuroMetrix May Struggle to Stay at Double-Digit Prices

By Thomas Niel, InvestorPlace Contributor

NURO stock is an interesting opportunity for sure. But it may be best to wait for it to head back to single-digit prices before buying.

There’s Only One Reason to Buy Sundial Stock at 80 Cents Per Share

By Thomas Niel, InvestorPlace Contributor

If you believe the possible gains from eventual U.S. pot law reform exceed the downside risk with SNDL stock? By all means, consider it a risky play worth cautiously taking.

7 Popular Stocks You Should Avoid At All Costs

By Thomas Niel, InvestorPlace Contributor

So, what are some of the top popular stocks to avoid? Or, if you own them now, cash out as soon as possible. Consider these seven, "meme stocks" and non-"meme stocks" alike, names to stay away from for now: AMC Entertainment (NYSE:AMC) Clover Health (NASDAQ:CLOV) Nio (NYSE:NIO) Palantir (NYSE:PLTR) Peloton (NASDAQ:PTON) SOS Ltd (NYSE:SOS) Virgin Galactic Holdings (NASDAQ:SPCE)

All Bets Are Off Whether Lucid Is Ready to Bounce Back

By Thomas Niel, InvestorPlace Contributor

Barring a Reddit rally or a market correction, expect LCID stock to hold steady, rather than surging (or sinking) in the near term.

With Better Crypto Mining Plays Out There, Why Bother With SOS Stock?

By Thomas Niel, InvestorPlace Contributor

There's still so little we understand about SOS stock. Given its many risks, regulatory pressure and lack of firm information, avoid it.

10 Penny Stocks to Buy to Create a $500 Portfolio

By Thomas Niel, InvestorPlace Contributor

These ten low-priced penny stocks have ample room to gain, making them each worthy of a small, speculative investment.

Despite Strengths, Oracle Stock Could Plateau From Here

By Thomas Niel, InvestorPlace Contributor

Even with its year-to-date run-up, ORCL stock is still more reasonably-priced than comparable big tech names.

Load More